# Role of Curcumin in Paclitaxel Induced PN

> **NCT05966441** · PHASE2 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 80 (estimated)

## Conditions studied

- Chemotherapy-induced Peripheral Neuropathy

## Interventions

- **DIETARY_SUPPLEMENT:** Curcumin
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT05966441
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-30
- **Primary completion:** 2023-12-15
- **Final completion:** 2024-03-10
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05966441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05966441, "Role of Curcumin in Paclitaxel Induced PN". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05966441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*